$RDHL

$0.45 +$0.03 (7.74%) Close

$RDHL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$RDHL Management Team

Mr. Dror Ben-Asher

Chairman of the Board

Chief Executive Officer

Age 58

Compensation $865.1K USD

Sex Male

Mr. Razi Ingber

Chief Financial Officer

Age 39

Compensation -

Sex Male

Mr. Gilead Raday

Chief Operating Officer

Age 48

Compensation $556.0K USD

Sex Male

Ms. Patricia Anderson

Senior Vice President - Regulatory Affairs

Age -

Compensation -

Sex Female

Dr. Reza Fathi

Senior Vice President - Research and Development

Age 68

Compensation $267.0K USD

Sex Male

Mr. Rick Scruggs

Chief Commercial Officer

Director

Age 63

Compensation $737.5K USD

Sex Male

Dr. June Almenoff

Chief Medical Officer

Age 67

Compensation -

Sex Female

Mr. Adi Frish

Chief Corporate and Business Development Officer

Age 54

Compensation $529.3K USD

Sex Male

Mr. Guy Goldberg

Chief Business Officer

Age 47

Compensation $221.4K USD

Sex Male

Mr. Alexandra Okmian

Investor Relations

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Dror Ben-Asher Chairman of the Board Chief Executive Officer	58	$865.1K USD	Male
Mr. Razi Ingber Chief Financial Officer	39	-	Male
Mr. Gilead Raday Chief Operating Officer	48	$556.0K USD	Male
Ms. Patricia Anderson Senior Vice President - Regulatory Affairs	-	-	Female
Dr. Reza Fathi Senior Vice President - Research and Development	68	$267.0K USD	Male
Mr. Rick Scruggs Chief Commercial Officer Director	63	$737.5K USD	Male
Dr. June Almenoff Chief Medical Officer	67	-	Female
Mr. Adi Frish Chief Corporate and Business Development Officer	54	$529.3K USD	Male
Mr. Guy Goldberg Chief Business Officer	47	$221.4K USD	Male
Mr. Alexandra Okmian Investor Relations	-	-	Male

Board of Directors

No proxy statement on record

Board of Directors comes from the company’s proxy statement. Redhill Biopharma Ltd has not filed one with the SEC.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Redhill Biopharma Ltd has not filed one with the SEC.

Comments